We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
(+24%)
Cap. Flow
+$552M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$39.4M |
| 3 |
Intel
INTC
|
+$29.2M |
| 4 |
Qualcomm
QCOM
|
+$27.6M |
| 5 |
Danaher
DHR
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$49.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$26.5M |
| 4 |
Arrowhead Research
ARWR
|
+$24.9M |
| 5 |
Merck
MRK
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.73% |
| 2 | Technology | 19.55% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
ManpowerGroup
MAN
$2.47B
| $202K | ﹤0.01% |
+2,078
| New | +$190K |
|
752
WEC Energy
WEC
$37.2B
| $202K | ﹤0.01% |
+2,189
| New | +$200K |
|
753
Accuray
ARAY
$26.9M
| $197K | ﹤0.01% |
70,000
-195,991
| -74% | -$544K |
|
754
Gold Fields
GFI
$29.4B
| $181K | ﹤0.01% |
27,438
+5,000
| +22% | +$28.3K |
|
755
ASE Group
ASX
$79.9B
| $150K | ﹤0.01% |
26,965
-89,460
| -77% | -$459K |
|
756
United Microelectronic
UMC
$48.1B
| $141K | ﹤0.01% |
52,725
-163,760
| -76% | -$395K |
|
|
FIT
757
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $131K | ﹤0.01% |
+20,000
| New | +$117K |
|
758
Ovintiv
OVV
$16.8B
| $124K | ﹤0.01% |
5,284
| – | – |
|
|
CHMA
759
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $117K | ﹤0.01% |
23,500
| – | – |
|
|
ACB
760
Aurora Cannabis
ACB
$169M
| $87K | ﹤0.01% |
337
+120
| +55% | +$44.7K |
|
761
Fortress Biotech
FBIO
$109M
| $58K | ﹤0.01% |
1,500
| – | – |
|
|
QCLS
762
Q/C Technologies Inc
QCLS
$25.6M
| $52K | ﹤0.01% |
3
| – | – |
|
763
Akebia Therapeutics
AKBA
$343M
| – | – |
-300,000
| Closed | -$1.18M |
|
764
Affiliated Managers Group
AMG
$9.55B
| – | – |
-3,132
| Closed | -$261K |
|
765
Autohome
ATHM
$2.46B
| – | – |
-4,000
| Closed | -$333K |
|
766
Badger Meter
BMI
$3.71B
| – | – |
-3,746
| Closed | -$201K |
|
767
C.H. Robinson
CHRW
$20.6B
| – | – |
-14,652
| Closed | -$1.24M |
|
|
CTRA
768
DELISTED
Coterra Energy
CTRA
| – | – |
-35,109
| Closed | -$617K |
|
769
Ecopetrol
EC
$32.4B
| – | – |
-175,000
| Closed | -$2.98M |
|
770
Gildan
GIL
$9.38B
| – | – |
-9,095
| Closed | -$323K |
|
|
CBIO
771
Crescent Biopharma
CBIO
$638M
| – | – |
-969
| Closed | -$418K |
|
772
Hawaiian Electric Industries
HE
$2.28B
| – | – |
-21,657
| Closed | -$988K |
|
|
IRBT
773
DELISTED
iRobot
IRBT
| – | – |
-135,508
| Closed | -$8.36M |
|
774
Kura Oncology
KURA
$929M
| – | – |
-138,100
| Closed | -$2.1M |
|
|
LITS
775
Lite Strategy Inc
LITS
$33.1M
| – | – |
-7,500
| Closed | -$252K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2019 Portfolio in Review
As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.
- Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
- Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
- Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
- Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
- Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
- Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
- Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.
Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.